News & Views
Protein could treat adult pulmonary hypertension
Oct 18 2011
Dr Yunchao Su, a pharmacologist and his team at Georgia Health Sciences University, published the study in Journal of Clinical Investigation, identifying the protein.
Calpain is a protein which is crucial to development, but it has been found to enable narrow, scarred blood vessels and pulmonary hypertension, which often occurs as a result of smoking or air pollution.
Pulmonary hypertension is a progressive and fatal condition that children can be born with, but which also appears in adults with chronic obstructive lung disease, or COPD, primarily caused by smoking or air pollutants, including second-hand smoke.
When the team blocked or removed calpain, TGFbeta was not activated and vascular remodelling and scarring as well as the heart damage were prevented, removing the need for heart-lung transplants.
"The pulmonary process was close to normal," Dr Su said.
He added that while a calpain inhibitor is not an option for children, an inhaled version could be a possibility for adults.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 22 2024 Marrakech, Morroco
Making Pharmaceuticals Exhibition & Conference
Apr 23 2024 Coventry, UK
Apr 23 2024 Kintex, South Korea
Apr 23 2024 Seoul, South Korea
Apr 24 2024 Jakarta, Indonesia